CN, did you read post #66000 yesterday on TRTC board. It's from Longanisa, who just joined here too (welcome!!). I believe it's very valuable info and worth spreading too. It proves NRTI has accomplished some really valuable stuff
I believe Phase 1 has to do with the process of extraction. According to the PR, "Innovation in cannabinoid extraction from food sources other than cannabis and hemp as well as leading technology to enhance bioavailability was our number one goal in this important phase of the initiative and we achieved it."
This was tantamount to what they are looking to do. If you can extract CBD from things other than hemp... this broadens the revenue possibilities.
and another thought...in addressing Bioavailability.
In pharmacology, bioavailability (BA) is a subcategory of absorption and is the fraction of an administered dose of unchanged drug that reaches the systemic circulation, one of the principal pharmacokinetic properties of drugs.
Basically, Phase 1 involves optimizing the potency.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.